The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Bristol-Myers Squibb; Intuitive Surgical; Johnson & Johnson; Merck
Consulting or Advisory Role - Tempus
Other Relationship - Dialectic Therapeutics
A phase Ia/Ib dose-escalation study of intravenously administered SB 11285 alone and in combination with nivolumab in patients with advanced solid tumors.
 
Filip Janku
Stock and Other Ownership Interests - Trovagene
Consulting or Advisory Role - Deciphera; Foundation Medicine; Guardant Health; IDEAYA Biosciences; IDEAYA Biosciences; IFM Therapeutics; Immunome; Jazz Pharmaceuticals; Novartis; PureTech; Sequenom; Sotio; Synlogic; Trovagene; Valeant/Dendreon
Research Funding - Agios (Inst); Asana Biosciences (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); Fujifilm (Inst); Genentech (Inst); Novartis (Inst); Piqur (Inst); Plexxikon (Inst); Proximagen (Inst); Roche (Inst); Symphogen (Inst)
Other Relationship - Bio-Rad
 
James Strauss
No Relationships to Disclose
 
Raghad Karim
No Relationships to Disclose
 
Anthony J. Olszanski
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Merck; Novartis; Pfizer
Research Funding - Adaptimmune (Inst); Alkermes (Inst); Astellas Pharma (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); EMD Serono (Inst); GlaxoSmithKline (Inst); GlycoNex (Inst); Immunocore (Inst); Incyte (Inst); Intensity Therapeutics (Inst); Kadmon (Inst); Kartos Therapeutics (Inst); Kura Oncology (Inst); Nektar (Inst); NGM Biopharmaceuticals (Inst); Oncoceutics (Inst); OncoSec (Inst); Seagen (Inst); Sound Biologics (Inst); Spring Bank (Inst); Takeda (Inst); Targovax (Inst)
 
Jason J. Luke
Stock and Other Ownership Interests - Actym Therapeutics; Alphamab; Kanaph Therapeutics; Mavu Pharmaceutical; Onc.AI; Pyxis; Tempest Therapeutics
Consulting or Advisory Role - 7 Hills Pharma; Abbvie; Actym Therapeutics; Aduro Biotech; Akrevia Therapeutics; Alphamab; Amgen; Array BioPharma; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Benevir; Bristol-Myers Squibb; Compugen; Eisai; EMD Serono; IDEAYA Biosciences; Immunocore; Incyte; Janssen; Jounce Therapeutics; Leap Therapeutics; Mavu Pharmaceutical; Merck; Mersana; Novartis; Partner Therapeutics; Reflexion Medical; Spring Bank; Synlogic; Tempest Therapeutics; TTC Oncology; Vividion Therapeutics
Research Funding - Abbvie (Inst); Array BioPharma; Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Checkmate Pharmaceuticals; Compugen (Inst); Corvus Pharmaceuticals (Inst); Delcath Systems (Inst); Evelo Therapeutics; Five Prime Therapeutics (Inst); FLX Bio; Genentech/Roche (Inst); Immunocore (Inst); Incyte (Inst); Macrogenics (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Palleon Pharmaceuticals; Pharmacyclics (Inst); Tesaro (Inst); Xencor (Inst)
Patents, Royalties, Other Intellectual Property - Serial #15/612,657 (Cancer Immunotherapy),; Serial #PCT/US18/36052 (Microbiome Biomarkers for Anti-PD-1/PD-L1 Responsiveness: Diagnostic, Prognostic and Therapeutic Uses Thereof)
Travel, Accommodations, Expenses - Akrevia Therapeutics; Amgen; Array BioPharma; AstraZeneca/MedImmune; Benevir; Bristol-Myers Squibb; Castle Biosciences; Checkmate Pharmaceuticals; EMD Serono; Gilead Sciences; IDEAYA Biosciences; Immunocore; Janssen; Jounce Therapeutics; Merck; Mersana; Novartis; Reflexion Medical
 
Kevin Leach
Employment - Spring Bank
Stock and Other Ownership Interests - Spring Bank
 
Radhakrishnan Iyer
Employment - Spring Bank
Stock and Other Ownership Interests - Spring Bank
 
Atif Abbas
Employment - Spring Bank